Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
INF-904 by InflaRx for Chronic Inflammation: Likelihood of Approval
INF-904 is under clinical development by InflaRx and currently in Phase I for Chronic Inflammation. According to GlobalData, Phase I...
Data Insights
INF-904 by InflaRx for Autoimmune Disorders: Likelihood of Approval
INF-904 is under clinical development by InflaRx and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I...